Develops and manufactures a wide range of vaccines for both companion and food-producing animals. Offers dental hygiene products specifically designed for pets. Now — the numbers.
This is an established company with proven profits.
Average growth of 8% a year over the last 4 years. Every year shown ended in profit.
The gap is $200.4M. In times of high interest rates, a gap like that can squeeze a company.
The market pays 18.3× for every dollar of annual profit — around what a business like this usually costs.
No analyst target is on record for this company.
The stock trades below its recent peak — about 12% off the top. A pullback, not a collapse.
Over the last 4 years, sales grew about 8% a year on average.
It pays out $1.66 per share each year — regular cash for whoever holds the stock.
Getting in and out without moving the price could prove difficult.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.